lidoflazine has been researched along with Injury, Myocardial Reperfusion in 2 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang-Chun, C | 1 |
| Masuda, M | 1 |
| Szabò, Z | 1 |
| Szerafin, T | 1 |
| Szècsi, J | 1 |
| Van Belle, H | 1 |
| Flameng, W | 1 |
| Guvendik, L | 1 |
| Hynd, J | 1 |
| Drake-Holland, A | 1 |
| Parker, DJ | 1 |
2 other studies available for lidoflazine and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Nucleoside transport inhibition mediates lidoflazine-induced cardioprotection during intermittent aortic crossclamping.
Topics: Adenosine; Aminophylline; Animals; Aorta; Biological Transport; Blood Pressure; Cardiac Output; Card | 1992 |
Myocardial protective effects of lidoflazine during ischemia and reperfusion.
Topics: Adenosine Triphosphate; Animals; Cardioplegic Solutions; Coronary Circulation; Dogs; Heart; Hemodyna | 1990 |